A new class of halobenzyloxy or alkoxy 1,2,4-triazoles and their hydrochlorides were synthesized through cyclization starting from commercially available phenylhydrazine. The structures were characterized by MS, IR and 1 H NMR spectra as well as elemental analyses. All the synthesized compounds were screened for their antibacterial activities in vitro against Staphylococcus aureus (ATCC29213), methicillin-resistant Staphylococcus aureus (N315), Bacillus subtilis, Escherichia coli (ATCC25922), Pseudomonas aeruginosa, Shigella dysenteriae, Eberthella typhosa, and antifungal activities against Candida albicans (ATCC76615), Aspergillus fumigatus by broth microdilution assay method. The results of preliminary bioassay indicated that 3-(2,4-difluorobenzyloxy)-1-phenyl-1H-1,2,4-triazole hydrochloride exhibited the best inhibitory activity with an MIC value of 56.25 µM against P. aeruginosa superior to Chloramphenicol, and showed comparable activity with Chloramphenicol against E. coli (ATCC25922).
Introduction
The incidence of systemic fungal infections such as candidosis, cryptococcosis, and aspergillosis has been rapidly increasing mainly due to the growing number of immunocompromised hosts in the past few decades. Similarly, the dramatically rising prevalence of multi-drug resistant microbial infections has recently become a serious health care problem. Particularly, the emergence of multi-drug-resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) has been a problem of ever-increasing significance in both community and hospital acquired infections.
1 Thus, there is a real perceived need for the discovery of new compounds with high efficiency, broad spectrum and low toxicity, which are structurally distinct from those of well known classes of antimicrobial agents to which many clinically relevant pathogens are now resistant. Consequently, the search for new molecular scaffolds will always remain an important and challenging task for medicinal chemists.
Azole compounds especially 1,2,4-triazole derivatives are quite important types of nitrogen-containing aromatic heterocyclic compounds endowed with excellent safety profile, favorable pharmacokinetic characteristics and wide biological activities. [2] [3] [4] [5] [6] [7] [8] [9] Noticeably, 1,2,4-triazoles as antimicrobial agents have aroused special attention in medicinal chemistry in recent years due to their prominent activity, low toxicity as well as broad spectrum. 10 So far a large number of 1,2,4-triazole antimicrobial compounds have been extensively used in clinic. 11 For example, Fluconazole shows good antifungal activity with relatively low toxicity and has been preferred as first-line antifungal therapy. 12 However, Fluconazole is not effective against invasive aspergillosis and has suffered severe drug resistance. Itraconazole is an improvement of Fluconazole in terms of having a broad antifungal spectrum and better toleration, whereas its use is hampered by variable oral absorption and low bioavailability. This situation has led to an ongoing search for new azoles. Very recently, a substantial effort has been devoted to the modification and optimization of the existing triazole antimicriobial agents which relied on the empirical development of a structure-activity relationship (SAR). 13 On the other hand, it is also an increasing prevalence of one such strategy that has been pursued in recent years to develop new antimicrobial agents with novel chemical structures, which could have modes of action rather than analogs of the existing ones.
In our ongoing interest in the development of new antimicrobial agents, 14-18 our attention has been focusing on the discovery of novel N-substituted 1,2,4-triazole compounds with structurally difference from the well known ones via N-alkylation of 1,2,4-triazole ring.
14, 15 Except that, there are still so many approaches that are available for the insertion of specific functionalities into the 1,2,4-triazole nucleus to build up diversified substituted 1,2,4-triazoles. [19] [20] [21] [22] [23] [24] [25] The alterations in chemical structure of substituted 1,2,4-triazoles could affect their interactions with cells and tissues, thereby exhibiting different biological effects. Furthermore, much research manifested that incorporation of fluorine or chlorine moiety into an organic molecule could efficiently improve the pharmacological properties, [26] [27] [28] [29] which resulted in increasing lipid solubility, accordingly enhancing the rate of absorption and transport of drugs in vivo. The replacement of hydrogen or hydroxyl group by fluorine or chlorine represents a valuable strategy and was extensively used in drug development to alter biological function. 30, 31 Meanwhile, the introduction of alkyl moiety into various heterocyclic systems as the large non-polar portion could play an important role in modulating the physicochemical properties of the whole molecule that possibly avoid some side effects and improve their pharmacokinetic and pharmacodynamic behaviors. This is also helpful to increase their biological activities. [32] [33] [34] On the basis of all above observations and as an extension of our studies on biologically active N-substituted 1,2,4-triazol- es derivatives, herein a series of novel halobenzyloxy and alkoxy 1,2,4-triazole compounds have been synthesized and evaluated for their antibacterial and antifungal activities in vitro. Additionally, their corresponding hydrochlorides were also prepared in order to investigate the effect of water solubility of target triazoles on the antimicrobial activities, and their structure-activity relationships were also discussed.
Results and Discussion
Chemistry. The synthetic route of halobenzyloxy or alkoxy 1,2,4-triazole derivatives 3-4 and their hydrochlorides 5-6 was outlined in Scheme 1. Phenylhydrazine 1 was first reacted with urea to give the intermediate phenylhydrazinecarboxamide, and then the later was cyclized with formic acid to afford the corresponding hydroxytriazole 2. 35 The etherification of 1-phenyl-1,2,4-triazole-3-ol (2) using halogen-substituted benzyl or alkyl halides in the presence of anhydrous potassium carbonate and TBAI afforded halobenzyloxy or alkoxy 1,2,4-triazoles (3a-g, 4a-e) in moderate to excellent yields (from 56% to 89%), and then treated in ethyl ether with HCl (4 mol/L) to give the corresponding hydrochlorides (5a-g, 6a-e) in high yields ranging from 81% to 88%.
Experimental results revealed that the ratio of reactants, solvent, reaction time, amount of catalyst as well as the addition rate of concentration sulfuric acid exerted important influences on the yield of hydroxytriazole (2) . Therefore, we optimized the cyclization conditions, and exploited an one-pot, three-component synthesis strategy to construct the 1,2,4-triazole ring, which represented an easy, convenient and efficient synthetic route.
The intermediate hydroxytriazole 2 involves two tautomeric forms. When it reacted with halogen-substituted benzyl or alkyl halides, it may be in the wake of obtaining the N-alkylation products in the O-alkylation reaction. The O-alkylation reaction was found to be highly sensitive to reaction temperature, solvent and pH. When the temperature was above 80 ºC, the reaction became complex, and thus led to poor yields. However, too low temperature (below 55 ºC) would not only greatly decrease the reactivity but also make the reaction sluggish enough to lower the yields. The optimal reaction temperature was at 70 -75 ºC in our study, which gave the highest yields. Moreover, the reaction failed as the pH was higher than 10 or less than 6. The results confirmed that the presence of weak base (K 2 CO 3 ) in acetonitrile at 70 -75 ºC with pH 7.5 -8.5 was favorable to this O-alkylation reaction.
It was also noticed that the presence of the triazole hydrochloride in compounds 5-6 resulted in a better water solubility in comparison with the corresponding precursors 3-4, while alkoxy triazole hydrochlorides possessed better solubility than halobenzyloxy ones in other solvents such as chloroform, tetrahydrofuran and acetone.
Analysis of spectra. All the synthesized compounds were confirmed by MS, IR and 1 H NMR spectra as well as elemental analyses. The spectral analyses were in accordance with the assigned structures, and all the characterization data were given in the experimental section. The mass spectra for the target compounds showed a major fragment of [ , 1290 -1200 cm -1 and 1110 -1000 cm -1 were respectively attributable to the stretching vibration of Ar-H, the anti-symmetric stretching vibration and the symmetric stretching vibration of C-O-C bonds. Moreover, it was found that all the vibration frequency in halobenzyloxy or alkoxy 1,2,4-triazoles was obviously shifted to higher wave numbers in contrast to their corresponding hydrochlorides, which was mainly responsible for the inductive effects of the positive charges in triazole moiety. For another, the H 2 C-O absorption bands in halobenzyloxy 1,2,4-triazoles were observed at higher frequency in comparison with that in alkoxy ones owing to the electrophilic inductive effects fluorine or chlorine moiety and conjugation effects of benzene ring in compounds 3a-g and 5a-g.
H NMR spectra:
The 1 H NMR spectra showed that two singlets at the region of 5.62 -4.34 ppm and 8.95 -7.84 ppm were assigned to the methylene protons of alkoxy or halobenzyloxy group and the N = CH protons of triazole ring in all title compounds respectively. Furthermore, the downfield shift of the methylene protons of the halobenzyl compounds was observed, in comparison with that in alkyl substituted 1,2,4-triazoles. In the 1 H NMR spectra, it was also found that all the triazole N = CH protons and the methylene protons in the hydrochlorides showed large downfield shifts compared to the corresponding precursors, probably ascribed to the presence of positive charges in the hydrochlorides. All the other aromatic and aliphatic protons appeared at the appropriate chemical shifts and integral values.
Biological activity. These halobenzyloxy and alkoxy 1,2,4-triazoles 3-4 and their hydrochlorides 5-6 were evaluated for their antimicrobial activities against MRSA (N315), S. aureus (ATCC29213) and B. subtilis as Gram-positive, E. coli (ATCC-25922), P. aeruginosa, S. dysenteriae and E. typhosa as Gramnegative bacteria, as well as C. albicans (ATCC76615) and A. fumigatus as fungi by broth microdilution assay method. Clinical antimicrobial drugs Chloramphenicol and Fluconazole were served as the positive control. The minimum inhibitory concentration (MIC, µM) values were compiled in Table 1 . Antibacterial activity: The investigation of antibacterial screening data revealed that some target compounds exhibited significant inhibitory activities against some tested strains such as B. subtilis and P. aeruginosa at 56.25 -475 µM in vitro. Especially, it was worthy to note that the compounds 3a and 3b as well as their corresponding hydrochlorides 5a and 5b bearing 2,4-difluorobenzyloxy and 2,4-dichlorobenzyloxy groups exhibited the most prominent activity against all bacterial strains tested at the concentration of 56.25 -450 µM, in comparison with other halobenzyloxy 1,2,4-triazoles, which was possibly attributed to the presence of pharmacologically active dihalophenyl moiety at position 3 of the triazole ring. That suggested that 2,4-dichlorobenzyl or 2,4-difluorobenzyl substitution in the triazole ring was suitable for antibacterial activity.
On basis of the bioactive data, it was observed that the antibacterial activities for alkoxy derivatives 4a-e and 6a-e were weaker in comparison to halobenzyloxy compounds 3a-g and 5a-g. However, compounds 4c, 4d and their hydrochlorides 6c, 6d containing long alkyl chains with lengths in the range of C8-C12 gave significant activities against some tested strains with MIC values ranging from 195 µM to 470 µM. Conversely, the antibacterial results showed no obvious inhibition for compounds 4a, 4b including their hydrochlorides 6a, 6b with short C2-C4 alkyl chain. Therefore, the introduction of linear alkyl with lengths in the range of C8-C12 into 1,2,4-triazole ring could enhance antibacterial activities.
The 4-nitrogen of triaozle ring is liable to quaternary, and formed into quaternary ammonium salt, which is favourable to improve water-solubility and enhance activities. In vitro studies demonstrated that all the halobenzyloxy and alkoxy 1,2,4-triazole hydrochlorides 5-6 exhibited better activities compared to the corresponding precursors 3-4, in particular, compound 5b possessed dramatic biological activities against nearly all tested strains with MIC values ranging from 56.25 µM to 450 µM, shown in Table 1 . Noticeably, compound 5b gave 15 -30 times higher potency than Chloramphenicol against B. subtilis and P. aeruginosa, with MIC values of 112.5 µM and 56.25 µM respectively, and exerted almost comparable inhibitory activity with respect to the standard drug Chloramphenicol against E. coli (ATCC25922). Surprisingly, compound 5b was observed to show potent activity against methicillin-resistant S. aureus (N315) with an MIC value of 450 µM.
Generally, the halobenzyloxy triazole derivatives 3a, 3b, 3c and 4d along with their hydrochlorides 5a, 5b, 5c and 6d containing dichlorobenzyloxy, difluorobenzyloxy, 4-fluorobenzyloxy and dodecyloxy moieties respectively, showed more potent antibacterial activity than other new compounds against some tested bacteria species, while the hydrochlorides with better water solubility exhibited enhanced activity in contrast to their corresponding compounds. All the results suggested the significant effect of the water-solubility of the compounds, the substitution of benzyloxy group as well as the length of linear alkyl chain in the 1,2,4-triazole ring on antibacterial activity.
Antifungal activity: The antifungal evaluation revealed that for almost all the synthesized halobenzyloxy and alkoxy 1,2,4-triazole derivatives, the activities were relatively weak compared to their antibacterial efficacy. However, it's worth mentioning that the 1,2,4-triazole hydrochlorides 5a and 5b displayed higher inhibitory activities against A. fumigatus than the reference drug Fluconazole with the low MIC values of 800 µM and 450 µM, respectively. All the newly synthesized compounds almost had no obvious inhibitory activity against C. albicans except for compounds 5a with 2,4-difluorobenzyloxy group and 6d consisting of the linear alkyl chain with length in C12, which showed remarkable antifungal activity toward C. albicans with MIC values of 200 µM and 390 µM, respectively. The other compounds exhibited poor or weak antifungal activity against all fungi tested.
Conclusion
In summary, a new type of halobenzyloxy 1,2,4-triazoles (3a-g) and alkoxy 1,2,4-triazoles (4a-e) as well as their corresponding hydrochlorides (5a-g, 6a-e) were synthesized successfully via cyclization using phenylhydrazine as starting material, and their antimicrobial activities were also evaluated. All these new compounds were confirmed by IR, MS, 1 H NMR spectra and elemental analyses. All results obtained from antibacterial and antifungal tests revealed that some of the present series carrying dihalobenzyloxy, octyloxy or dodecyloxy groups exhibited moderate antimicrobial activities in vitro. Noticeably, compound 3b containing difluorobenzyloxy and its hydrochloride 5b showed the most potent activity against P. aeruginosa and E. coli with the MIC values of 112.5 µM and 56.25 µM respectively. The study of preliminary structure-activity relationships delineated that the type of substituent and the length of alkyl chain in the new compounds are responsible for the variation of the antimicrobial activities. Moreover, the water-solubility of the tested compounds has important effect on their biological activities. Further investigations are in progress for this class of heterocyclic compounds.
Experimental
Chemistry. Melting points are uncorrected and were recorded on X-6 melting point apparatus. Thin layer chromatography (TLC) was performed using pre-coated silica gel plates and visualization was obtained by exposure to iodine vapors and / or under UV light (254 nm). FT-IR spectra were recorded on Bruker RFS100/S spectrophotometer (USA) using KBr pellets in the 400 -4000 cm -1 range.
1 H-NMR spectra were determined with a Bruker AV 300 MHz spectrometer and were reported in δ units (ppm) relative to tetramethylsilane (TMS) as an internal standard. The chemical shifts are expressed in parts per million (d) and following abbreviations were used: s = singlet; bs = broad singlet; d = doublet; t = triplet; m = multiplet. The mass spectra were recorded on FINNIGAN TRACE GC-MS 2000 mass spectrometer (Thermo Electron Corporation, Bremen, Germany). Elemental analyses were carried out on a ERBA1106 (Carlo Erba, Milan, Italy). All chemicals and solvents were commercially available, reagent grade, and were used without further purification.
Synthesis of 1-phenyl-1H-1,2,4-triazol-3-ol (2).
The mixture of phenylhydrazine (2.8 g, 26 mmol) and urea (4.9 g, 82 mmol) was dissolved in 6 mL H2O with stirring at 90 ºC. Subsequently, concentrated sulfuric acid (4.2 g, 42 mmol) was added by a dropping funnel with stirring. After that, the mixture was refluxed for 5 -9 h at 100 ºC until the starting material was almost consumed (monitored by TLC, eluent, chloroform/acetone, 10/1, v/v), and then set down the temperature to 90 ºC, added HCO-OH (3.7 g, 82 mmol) to the flask and stirred for 16 -20 h under 125 ºC until the reaction was over (monitored by TLC, eluent, chloroform/acetone, 3/1, v/v). The reacting mixture was cooled to room temperature, and then the resultant yellow precipitate was filtered and washed with water until pH 6.5. The crude product was purified by recrystallization from acetic acid to afford white solid in 88% yield, mp 281 -282 ºC, which is according with the reference.
35
Synthesis of halobenzyloxy 1,2,4-triazoles (3a-g). To a flask containing hydroxyltriazole 2 (200 mg) in 10 mL CH3CN was added 200 mg (14.5 mmol) of anhydrous potassium carbonate and stirred for 30 min at 65 ºC. Then 5 mg of tetrabutyl ammonium iodide (TBAI) and equimolar halobenzyl bromide or chloride were added and the mixture was stirred at 70 -75 ºC for 5 -7 h (monitored by TLC, eluent, chloroform). After cooling, the reaction mixture was evaporated under reduced pressure, treated with water (10 mL), and then extracted with chloroform (3 × 10 mL). The organic layers were combined, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The resulting residue was purified via silica gel column chromatography (eluent, chloroform) and recrystallized from the mixture solvent of chloroform and petroleum ether (30 - 
Synthesis of alkoxy 1,2,4-triazoles (4a-e).
A suspension of hydroxytriazole 2 (200 mg) and anhydrous potassium carbonate (200 mg, 14.5 mmol, 1.2 equiv) in CH3CN (10 mL) was stirred for 30 min at 65 ºC. Then tetrabutyl ammonium iodide (TBAI, 5 mg) and equimolar alkyl bromide were added to the suspension and the mixture was stirred at 70 -75 ºC for 5 -7 h (monitored by TLC, eluent, chloroform). After cooling, the solvent was evaporated under reduced pressure. Then, the residue was poured into water (10 mL) and extracted with chloroform (3 × 10 mL). The organic layer was separated, dried over anhydrous Na2SO4 and evaporated under reduced pressure to give the crude product, which was purified by silica gel column chromatography (eluent, chloroform) to give the desired compounds 4a-e. Synthesis of halobenzyloxy 1,2,4-triazole hydrochlorides (5a-g). To a solution of halobenzyloxy 1,2,4-triazoles 3a-g (100 mg) in ethyl ether (10 mL) was added hydrochloride acid (10 mL, 4 mol/L). The mixture was stirred at room temperature for 5 -6 h and the solvent was evaporated to afford the corresponding hydrochlorides 5a-g. Some salts were highly hydroscopic and no sharp melting points could be observed. 
Synthesis of alkoxy 1,2,4-triazole hydrochlorides (6a-e).
To a well-stirred suspension of alkoxy 1,2,4-triazoles 4a-e (100 mg) in ethyl ether (10 mL) was added hydrochloride acid (10 mL, 4 mol/L). After the addition, the resulting mixture was stirred at room temperature for 5 -6 h, and then the solvent was removed to afford the hydrochlorides 6a-e. Hexadecyloxy)-1-phenyl-1H-1,2,4- All compounds were evaluated for their antibacterial activities against S. aureus (ATCC29213) and B. subtilis as Gram-positive, E. coli (ATCC25922), P. aeruginosa, S. dysenteriae and E. typhosa as Gram-negative bacteria, as well as their antifungal activity against C. albicans (ATCC76615) and A. fumigatus, at the concentrations of the antimicrobial agents ranging from 0.5 µg/mL to 512 µg/mL and scored for MIC50 as the level of growth inhibition of the tested microorganisms. The minimum inhibitory concentration (MIC) values (in µM) were summarized in Table 1. 
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